Abstract
We used Salmonella enteritidis serotype dublin strain SL1438, a nonreverting, aromatic-dependent, histidine-requiring mutant, as a recipient for a recombinant plasmid coding for production of the nontoxic B subunit of the heat-labile Escherichia coli enterotoxin. The S. enteritidis derivative EL23 produced heat-labile enterotoxin subunit B that was indistinguishable from heat-labile enterotoxin subunit B produced by strains of E. coli or Salmonella typhi harboring the same plasmid. Mice immunized orally with strain EL23 developed progressively increasing mucosal and serum antibody responses to both heat-labile enterotoxin subunit B and to the lipopolysaccharide of the vaccine strain. The mucosal antibody response was shown to be immunoglobulin A specific and to be capable of neutralizing the biological activities of both E. coli heat-labile enterotoxin and cholera enterotoxin in vitro.
MeSH Terms
Administration, Oral
Animals
Antitoxins/analysis
Bacterial Toxins/genetics,immunology
Bacterial Vaccines/immunology
Cholera Toxin/genetics
DNA, Recombinant
Enterotoxins/genetics,immunology
Escherichia coli Proteins
Female
Immunization
Immunoglobulin A/analysis
Immunoglobulin G/analysis
Lipopolysaccharides/immunology
Mice
Mice, Inbred BALB C
Plasmids
Salmonella enteritidis/genetics,immunology
Vaccines, Attenuated/immunology
Chemicals
Antitoxins
Bacterial Toxins
Bacterial Vaccines
DNA, Recombinant
Enterotoxins
Escherichia coli Proteins
Immunoglobulin A
Immunoglobulin G
Lipopolysaccharides
Vaccines, Attenuated
heat-labile enterotoxin, E coli
Cholera Toxin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Clements J D
Lyon F L
Lowe K L
Farrand A L
el-Morshidy S
References (27)
27 references, click to expand
-
Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.
J Exp Med. 1969 Jul 1;130(1):185-202
PMID: 4978880
-
Intracellular distribution of heat-labile enterotoxin in a clinical isolate of Escherichia coli.
Infect Immun. 1985 Oct;50(1):317-9
PMID: 3899935
-
Studies on toxinogenesis in Vibrio cholerae. I. Isolation of mutants with altered toxinogenicity.
J Infect Dis. 1974 Feb;129(2):117-23
PMID: 4129825
-
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture.
Infect Immun. 1975 Feb;11(2):334-6
PMID: 1089601
-
Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.
J Infect Dis. 1975 May;131(5):553-8
PMID: 1092768
-
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.
J Infect Dis. 1977 Dec;136(6):717-23
PMID: 925379
-
Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants.
Infect Immun. 1978 May;20(2):552-8
PMID: 669812
-
Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.
Infect Immun. 1978 Sep;21(3):1036-9
PMID: 361573
-
Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.
Infect Immun. 1978 Dec;22(3):709-13
PMID: 83301
-
Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.
Proc Natl Acad Sci U S A. 1979 Apr;76(4):2052-6
PMID: 109838
-
Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.
Infect Immun. 1979 Jun;24(3):760-9
PMID: 89088
-
Antigenic specificity of neutralizing antibody to cholera toxin.
Infect Immun. 1979 Jun;24(3):774-9
PMID: 89089
-
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res. 1979 Nov 24;7(6):1513-23
PMID: 388356
-
Properties of homogeneous heat-labile enterotoxin from Escherichia coli.
Infect Immun. 1980 Jul;29(1):91-7
PMID: 6156914
-
A controlled field trial of liver oral typhoid vaccine Ty21a.
Bull World Health Organ. 1980;58(3):469-74
PMID: 6998594
-
Actions of cholera toxin and the prevention and treatment of cholera.
Nature. 1981 Jul 30;292(5822):413-17
PMID: 7019725
-
Cloned cholera enterotoxin genes in study and prevention of cholera.
Lancet. 1981 Nov 21;2(8256):1162-3
PMID: 6118594
-
Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.
Infect Immun. 1981 Dec;34(3):746-50
PMID: 6174449
-
Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.
Infect Immun. 1982 Apr;36(1):221-6
PMID: 7076295
-
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.
Gene. 1982 Oct;19(3):259-68
PMID: 6295879
-
Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.
Nature. 1983 Dec 8-14;306(5943):551-7
PMID: 6646234
-
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.
Microbiol Rev. 1983 Dec;47(4):510-50
PMID: 6363898
-
Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
J Infect Dis. 1984 Feb;149(2):133-6
PMID: 6366077
-
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.
Nature. 1984 Apr 12-18;308(5960):655-8
PMID: 6324005
-
Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.
Infect Immun. 1984 Nov;46(2):564-9
PMID: 6389350
-
Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves.
Am J Vet Res. 1984 Nov;45(11):2231-5
PMID: 6395725
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5
PMID: 5432063